HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

HIV | Image credit: reddish - stock.adobe.com
Family Dynamics, Mental Health Influence Adherence to ART

April 29th 2025

Improving adherence to antiretroviral therapy (ART) in youth living with HIV requires interventions that target both family dynamics and any underlying mental illness.

Richard Hughes IV, JD, MPH
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

April 21st 2025

Women with HIV | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com
Poor Well-Being in HIV Associated With SDOH Adversities

April 16th 2025

Money | Image credit: Stillfx - stock.adobe.com
Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

April 3rd 2025

HIV Prevention | Image credit: Nadzeya - stock.adobe.com
Elimination of Division of HIV Prevention Could Have Consequences for HIV Response

March 25th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
May 2nd 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

Immunotherapy Is Safe for Patients With Cancer Living With HIV
October 25th 2018

Immunotherapy Is Safe for Patients With Cancer Living With HIV

Jaime Rosenberg
According to a study presented at the ESMO 2018 Congress in Munich, Germany, treatment with PD-1 or PD-L1 inhibitors is a feasible option for patients who have cancer and are living with HIV.
Site Logo
October 23rd 2018

Drug Market to See More Competition, Launch of Biosimilars in 2019

Mary Caffrey
Express Scripts' Aimee Tharaldson, PharmD, gave her overview of the specialty pharmacy pipeline for 2019 and beyond at the Academy of Managed Care Pharmacy Nexus 2018 meeting in Orlando, Florida.
Population-Level PrEP Roll-Out Associated With Rapid Decline in HIV Diagnoses
October 18th 2018

Population-Level PrEP Roll-Out Associated With Rapid Decline in HIV Diagnoses

Jaime Rosenberg
A population-level roll-out of pre-exposure prophylaxis (PrEP) for HIV in men who have sex with men resulted in a 25% reduction in HIV diagnoses in just 1 year.
Trial Will Examine Novel HIV Vaccine Candidate Designed to Stimulate Immune Response
October 17th 2018

Trial Will Examine Novel HIV Vaccine Candidate Designed to Stimulate Immune Response

Jaime Rosenberg
The novel vaccine—eOD-GT8 60mer—stimulates the immune system to initiate a key first step in the generation of potent proteins, known as broadly neutralizing antibodies.
HHS Awards $2.34 Billion in Grants to Ryan White HIV/AIDS Program
October 12th 2018

HHS Awards $2.34 Billion in Grants to Ryan White HIV/AIDS Program

Jaime Rosenberg
Today, HHS announced that approximately $2.34 billion in Ryan White HIV/AIDS Program grants were awarded to cities, counties, states, and local community-based organizations during fiscal year 2018.
Symtuza Achieves, Maintains Viral Suppression in Patients With HIV
October 9th 2018

Symtuza Achieves, Maintains Viral Suppression in Patients With HIV

Jaime Rosenberg
Treatment with Symtuza (darunavir 800 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir alafenamide 10 mg) results in and maintains high virologic suppression rates, according to study findings presented at the 2018 Infectious Disease Week conference held in San Francisco, California.
Collaborative, Multidisciplinary Care Has Positive Impact on Viral Suppression in HIV
October 3rd 2018

Collaborative, Multidisciplinary Care Has Positive Impact on Viral Suppression in HIV

Jaime Rosenberg
Two studies presented at the 2018 Infectious Disease Week conference held in San Francisco, California, add to a pile of research demonstrating the positive impact of collaborative, multidisciplinary care in the HIV population, specifically on viral suppression.
People Living With HIV Have Higher Risk of First and Second Primary Cancer Incidence
October 2nd 2018

People Living With HIV Have Higher Risk of First and Second Primary Cancer Incidence

Jaime Rosenberg
A new study has found that people living with HIV are at an increased risk of both first and second primary cancer incidence.
Text Message Intervention Improves PrEP Adherence Among MSM at Risk for HIV
September 28th 2018

Text Message Intervention Improves PrEP Adherence Among MSM at Risk for HIV

Jaime Rosenberg
Young men who have sex with men (MSM) who used the PrEPmate intervention were more likely to attend study visits and have higher rates of adherence to the prevention treatment.
Unstable Housing Has Adverse Impact on Viral Suppression, CD4 Cell Count in HIV Population
September 24th 2018

Unstable Housing Has Adverse Impact on Viral Suppression, CD4 Cell Count in HIV Population

Jaime Rosenberg
Unstable housing among the HIV population is associated with decreased probability of viral suppression and adequate CD4 cell count. It also lowers the likelihood of mental health/counseling, visiting a healthcare provider, and engaging in continuity of care.
Podcast: This Week in Managed Care—Banning Gag Clauses and Other Health News
September 22nd 2018

Podcast: This Week in Managed Care—Banning Gag Clauses and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: September 21, 2018
September 21st 2018

This Week in Managed Care: September 21, 2018

This week, the top managed care news included the Senate overwhelmingly voting to ban pharmacist gag clauses; a study found the current vaccine pipeline for HIV, tuberculosis, and malaria may fall short; an expert noted a trend of healthcare cost data seeping into nonhealthcare companies’ earnings calls.
More Than 25% of HIV Providers Don't Know If Their State Expanded Medicaid
September 20th 2018

More Than 25% of HIV Providers Don't Know If Their State Expanded Medicaid

Jaime Rosenberg
A survey has revealed gaps in HIV providers’ knowledge of the Affordable Care Act. However, despite these gaps, the majority of surveyed providers expressed belief that Medicaid expansion would improve both HIV outcomes and general outcomes for patients with the disease.
Launch of Highly Efficacious HIV, Tuberculosis, and Malaria Vaccines Unlikely, Study Says
September 18th 2018

Launch of Highly Efficacious HIV, Tuberculosis, and Malaria Vaccines Unlikely, Study Says

Jaime Rosenberg
Researchers determined that the current drug pipeline is unlikely to produce any highly effective vaccines for HIV, tuberculosis, or malaria, which could be important for controlling the spread of these diseases.
Medication Adherence Program for HIV Needs Collaboration Among Physicians, Nurses, and Pharmacists
September 15th 2018

Medication Adherence Program for HIV Needs Collaboration Among Physicians, Nurses, and Pharmacists

David Bai
A descriptive, observational study in Switzerland implemented an interprofessional medication adherence program (IMAP) in patients with HIV. The framework for the implementation of services in pharmacy (FISpH) model is described and formulated for other healthcare facilities and professionals to evaluate and execute for themselves.
AJMC® in the Press, September 14, 2018
September 14th 2018

AJMC® in the Press, September 14, 2018

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
California Medicaid Expansion Had Mixed Effects for HIV Population
September 11th 2018

California Medicaid Expansion Had Mixed Effects for HIV Population

Jaime Rosenberg
With the expansion of Medicaid, eligible, low-income people living with HIV were transferred from the Ryan White Program to Medicaid, causing concern for interrupted access to care and treatment.
HIV/AIDS Research Has Positive Impacts Across Other Medical Fields
September 6th 2018

HIV/AIDS Research Has Positive Impacts Across Other Medical Fields

Jaime Rosenberg
In addition to the advances made in the HIV space, such as antiretroviral therapies and pre-exposure prophylaxis, the years of research has translated into advances outside the HIV field, including in oncology and other immune diseases.
Report: States Can Improve HIV Care Through Medicaid, Ryan White Program Collaboration
September 6th 2018

Report: States Can Improve HIV Care Through Medicaid, Ryan White Program Collaboration

Jaime Rosenberg
In a 3-part series, the National Academy for State Health Policy explored how states can use policy levers to more effectively utilize limited resources and provide better care, improve care coordination services, and ensure consistent access to care for people living with HIV.
Closing Treatment Gaps Critical for Ending HIV Epidemic in United States
August 30th 2018

Closing Treatment Gaps Critical for Ending HIV Epidemic in United States

Jaime Rosenberg
Targeted treatment interventions for populations with low levels of viral suppression, paired with tailored prevention packages, will be essential to ending the HIV epidemic in the United States, say researchers.
Patients With HIV Will Forgo Short Wait Time, Travel Distance to Access Nice Providers
August 28th 2018

Patients With HIV Will Forgo Short Wait Time, Travel Distance to Access Nice Providers

Jaime Rosenberg
Patients with HIV indicated a strong preference for “nice” over “rude” providers and a willingness to wait 19 hours more or travel 28 miles farther to see nice rather than rude providers.
PrEP for HIV Serves as Gateway to Primary Care
August 24th 2018

PrEP for HIV Serves as Gateway to Primary Care

Jaime Rosenberg
Researchers found that pre-exposure prophylaxis (PrEP) usage is linked to routine care, such as influenza vaccination, tobacco and depression screening, and glucose testing.
Between 1997 and 2015, Viral Suppression Rates Nearly Tripled in People Living With HIV
August 21st 2018

Between 1997 and 2015, Viral Suppression Rates Nearly Tripled in People Living With HIV

Jaime Rosenberg
The emergence and uptake of antiretroviral therapy (ART) has led to significant improvements in viral suppression rates over the past 2 decades.
Site Logo
August 16th 2018

Impact of a Medical Home Model on Costs and Utilization Among Comorbid HIV-Positive Medicaid Patients

Paul Crits-Christoph, PhD Robert Gallop, PhD Elizabeth Noll, PhD Aileen Rothbard, ScD Caroline K. Diehl, BS Mary Beth Connolly Gibbons, PhD Robert Gross, MD, MSCE Karin V. Rhodes, MD, MS
Among HIV-positive Medicaid patients with comorbid medical and psychiatric disorders, there was increased outpatient service utilization, yet relative cost savings, for patients who were treated in patient-centered medical homes.
Putting AIDS 2018 Into Perspective: Policy, Advocacy Implications
August 15th 2018

Putting AIDS 2018 Into Perspective: Policy, Advocacy Implications

Jaime Rosenberg
Contrasting the excitement and optimism coming out of clinical research presented at the AIDS 2018 conference, there was a sobering takeaway in the political and advocacy sphere. Among the general consensus that we are in a fragile moment in time, there were several policies and advocacy efforts that made it to the forefront of the conference.
Putting AIDS 2018 Into Perspective: Clinical Implications
August 14th 2018

Putting AIDS 2018 Into Perspective: Clinical Implications

Jaime Rosenberg
The 2018 International AIDS Conference in Amsterdam brought a plethora of new clinical implications for HIV care, reflecting ongoing investments in research efforts and optimism across all clinical domains, including vaccines, prevention, and new treatment approaches. However, with the excitement also came caution in other areas, such as stagnant incidence rates.
Individuals With HIV Are Twice as Likely to Develop Cardiovascular Disease, Study Finds
August 11th 2018

Individuals With HIV Are Twice as Likely to Develop Cardiovascular Disease, Study Finds

Alison Rodriguez
People living with HIV are twice as likely to develop cardiovascular disease and the global burden of HIV associated with cardiovascular disease has tripled over the last 2 decades.
Janssen Releases New Data Confirming Safety and Efficacy of Symtuza for HIV
August 9th 2018

Janssen Releases New Data Confirming Safety and Efficacy of Symtuza for HIV

Jaime Rosenberg
A month after Symtuza's approval, Janssen announced new switch data on the treatment and a second study supporting its use in a rapid initiation scenario.
PEPFAR, Elton John Reaffirm Commitment to, Investment in HIV Support for Key Populations
August 3rd 2018

PEPFAR, Elton John Reaffirm Commitment to, Investment in HIV Support for Key Populations

Jaime Rosenberg
During the 2018 International AIDS Conference, the US President’s Emergency Plan for AIDS Relief (PEPFAR) and the Elton John AIDS Foundation revealed initial results from the LGBT Fund, which they launched in 2016. PEPFAR also announced over $360 million in funding over the next 12 months.
Neurological Disabilities More Likely in Children With HIV
August 2nd 2018

Neurological Disabilities More Likely in Children With HIV

Jaime Rosenberg
Developmental issues, such as impaired brain growth, are more likely to occur in children with HIV than those without the virus.
<1
...
202122232425262728
...
32>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo